Following the cyber attack suffered by the Pierre Fabre Group on March 31, IT remediation operations have enabled the company's main operations to gradually return to normal.
Following the resumption of distribution activities on April 15, the Group's main plants at Gien (pharmaceuticals), Soual (dermo-cosmetics) and Avène (dermo-cosmetics) gradually resumed industrial production on Monday April 26. The Gaillac plant, which manufactures pharmaceutical and dermo-cosmetic active ingredients, was able to continue operations.
In France and abroad, sales activity has never been interrupted, and distribution operations have now resumed normally in all Group subsidiaries.
Thanks to safety stocks and the continuation of priority deliveries, the Group was able to ensure the continued availability of its therapeutic treatments to patients. In addition, stocks of dermo-cosmetic products held by wholesalers, distributors and pharmacists were generally sufficient to absorb consumer demand.
As a precautionary measure, and in line with its forward-looking risk management plan, the Group's IT system was immediately put on standby on March 31 to prevent the virus from spreading. Customers, partners and health authorities were kept regularly informed of the situation, and a complaint was lodged after the attack was claimed.
As part of the remediation operations, all the Group's IT systems and media have been reviewed to verify or restore their integrity, and to reinforce their security.
